SCHEMBL7532157

SCHEMBL7532157

Cc1c(C(=O)NN=Cc2ccc(Cl)cc2)[nH]c2cc(Cl)ccc12

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.83
KMT2A Q03164 5/20 0.83
MEN1 O00255 4/20 0.83
LMNA P02545 2/20 0.83
THRB P10828 2/20 0.83
SMN1; SMN2 Q16637 2/20 0.83
KDM4E B2RXH2 3/20 0.70
ALDH1A1 P00352 3/20 0.70
NPC1 O15118 1/20 0.55
GAA P10253 2/20 0.52
MGAM O43451 1/20 0.52
SI P14410 1/20 0.52
MGAM2 Q2M2H8 1/20 0.52
TUBB4A P04350 2/20 0.51
TUBB P07437 2/20 0.51
TUBA3C P0DPH7 2/20 0.51
TUBA1B P68363 2/20 0.51
TUBA4A P68366 2/20 0.51
TUBB4B P68371 2/20 0.51
TUBB3 Q13509 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7566603 1.00 MAPT (0.83) MAPTKMT2AMEN1LMNATHRB
SCHEMBL7673063 0.91 MAPT (0.70) MAPTKMT2AMEN1LMNATHRB
SCHEMBL7527624 0.91 MAPT (0.70) MAPTKMT2AMEN1LMNATHRB
SCHEMBL7526537 0.90 MAPT (0.69) MAPTKMT2AMEN1LMNATHRB
SCHEMBL7678818 0.90 MAPT (0.69) MAPTKMT2AMEN1LMNATHRB
SCHEMBL7679523 0.89 MAPT (0.70) MAPTKMT2AMEN1LMNATHRB
SCHEMBL7531926 0.89 MAPT (0.70) MAPTKMT2AMEN1LMNATHRB
SCHEMBL7528319 0.84 MAPT (0.69) MAPTKMT2AMEN1LMNATHRB
SCHEMBL7672079 0.84 MAPT (0.69) MAPTKMT2AMEN1LMNATHRB
SCHEMBL6842346 0.84 MAPT (1.00) MAPTKMT2AMEN1LMNATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors ABBOTT LABORATORIES 2002-07-11 US claimed
WO-2002022576-A2 3-SUBSTITUTED INDOLE CARBOHYDRAZIDES USEFUL AS CELL PROLIFERATION AND ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 2002-03-21 WO claimed
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors ABBOTT LABORATORIES 2002-07-11 US disclosed
WO-2002022576-A2 3-SUBSTITUTED INDOLE CARBOHYDRAZIDES USEFUL AS CELL PROLIFERATION AND ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 2002-03-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors MKI67, FLT4, IDO1 MAPT 4828/4885KMT2A 2765/4885MEN1 3165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.